PFM Health Sciences’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14.3M | Buy |
28,496
+13,664
| +92% | +$6.56M | 1.23% | 29 |
|
|
2026
Q1 | $7.29M | Sell |
14,832
-23,083
| -61% | -$12.5M | 0.66% | 48 |
|
|
2025
Q4 | $22M | Buy |
37,915
+35,601
| +1,539% | +$20.1M | 2.19% | 12 |
|
|
2025
Q3 | $1.12M | Buy |
+2,314
| New | +$1.08M | 0.09% | 69 |
|
|
2025
Q2 | – | Sell |
-21,897
| Closed | -$10.9M | – | 73 |
|
|
2025
Q1 | $10.9M | Buy |
21,897
+857
| +4% | +$464K | 0.79% | 33 |
|
|
2024
Q4 | $10.9M | Sell |
21,040
-37,393
| -64% | -$20.6M | 0.68% | 43 |
|
|
2024
Q3 | $36.1M | Sell |
58,433
-5,217
| -8% | -$3.09M | 2.05% | 15 |
|
|
2024
Q2 | $35.2M | Buy |
63,650
+5,612
| +10% | +$3.22M | 1.74% | 21 |
|
|
2024
Q1 | $33.7M | Buy |
58,038
+6,710
| +13% | +$3.77M | 1.59% | 23 |
|
|
2023
Q4 | $27.2M | Sell |
51,328
-10,815
| -17% | -$5.23M | 1.63% | 22 |
|
|
2023
Q3 | $31.5M | Hold |
62,143
| – | – | 1.48% | 30 |
|
|
2023
Q2 | $32.4M | Hold |
62,143
| – | – | 1.26% | 36 |
|
|
2023
Q1 | $35.8M | Hold |
62,143
| – | – | 1.58% | 30 |
|
|
2022
Q4 | $34.2M | Hold |
62,143
| – | – | 1.23% | 35 |
|
|
2022
Q3 | $31.5M | Hold |
62,143
| – | – | 1.14% | 42 |
|
|
2022
Q2 | $33.8M | Hold |
62,143
| – | – | 1.29% | 34 |
|
|
2022
Q1 | $36.7M | Hold |
62,143
| – | – | 1.37% | 33 |
|
|
2021
Q4 | $41.5M | Sell |
62,143
-9,299
| -13% | -$5.81M | 1.41% | 36 |
|
|
2021
Q3 | $40.8M | Buy |
71,442
+36,613
| +105% | +$20.1M | 1.2% | 39 |
|
|
2021
Q2 | $17.6M | Buy |
+34,829
| New | +$16.4M | 0.55% | 51 |
|
|
2019
Q3 | – | Sell |
-160,666
| Closed | -$47.2M | – | 103 |
|
|
2019
Q2 | $47.2M | Sell |
160,666
-120,770
| -43% | -$33.3M | 0.9% | 40 |
|
|
2019
Q1 | $77M | Buy |
281,436
+19,329
| +7% | +$4.81M | 1.7% | 24 |
|
|
2018
Q4 | $58.7M | Buy |
+262,107
| New | +$61.5M | 1.56% | 27 |
|
|
2015
Q1 | – | Sell |
-419,210
| Closed | -$52.5M | – | 99 |
|
|
2014
Q4 | $52.5M | Buy |
+419,210
| New | +$51M | 1.23% | 28 |
|
|
2014
Q3 | – | Sell |
-178,193
| Closed | -$21M | – | 72 |
|
|
2014
Q2 | $21M | Sell |
178,193
-458,563
| -72% | -$54M | 0.42% | 48 |
|
|
2014
Q1 | $76.6M | Sell |
636,756
-3,672
| -0.6% | -$437K | 1.39% | 25 |
|
|
2013
Q4 | $71.3M | Sell |
640,428
-1,748,818
| -73% | -$174M | 1.43% | 27 |
|
|
2013
Q3 | $220M | Sell |
2,389,246
-127,990
| -5% | -$11.6M | 5.3% | 2 |
|
|
2013
Q2 | $213M | Buy |
+2,517,236
| New | +$210M | 4.43% | 5 |
|
Other funds holding TMO
PFM Health Sciences's TMO Position: Q2 2026 in Review
PFM Health Sciences increased its Thermo Fisher Scientific (TMO) stake by 92% in Q2 2026, buying an estimated $6.56M and bringing the position to 28,496 shares worth $14.3M. The position accounts for 1.23% of the portfolio, ranked #29.
PFM Health Sciences first reported a position in TMO in Q2 2013 and has held it in 29 quarters since. The position peaked at $220M in Q3 2013. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- PFM Health Sciences held 28,496 shares of Thermo Fisher Scientific worth $14.3M as of Q2 2026.
- PFM Health Sciences bought 13,664 Thermo Fisher Scientific shares in Q2 2026, an estimated $6.56M.
- Thermo Fisher Scientific made up 1.23% of PFM Health Sciences's portfolio in Q2 2026, its #29 holding.
- PFM Health Sciences first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 29 quarters since.
- PFM Health Sciences's Thermo Fisher Scientific position peaked at $220M in Q3 2013.
- 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.